Titlebook: Drugs from Nature: Targets, Assay Systems and Leads; Madhathilkovilakathu Haridas,Sabu Abdulhameed,Swar Book 2024 The Editor(s) (if applic

窩轉(zhuǎn)脊椎動(dòng)物

Ayurveda-Inspired Reverse Pharmacology in Drug Discovery, in drug discovery is provided. Some of the drugs developed through this approach are discussed here as case studies. While there are challenges and limitations to this approach, deriving novel therapeutic applications from the existing formulation and developing safer drugs from natural sources represent crucial benefits.

obnoxious

反叛者

背書(shū)

ural sources against serious diseases.Provides a comprehensi.This book provides an overview of the drug discovery process from natural sources such as plants and microbes. While technological advances have streamlined the drug discovery process, enhancing the throughput and success rates, the struct

兩棲動(dòng)物

The Process of Drug Development from Natural Sources,ogies utilized in the process of discovering and developing drugs. In addition, drug development methodologies, application of computational chemistry principles, and modern techniques utilized for structural elucidation are discussed.

Control-Group

Largess

武器

Natural Drugs Through Plant Cell Suspension Culture, (PCS) culture and bioengineering approaches. This book chapter focuses on the various secondary metabolites found in plants, applications of PCS, strategies employed to increase the yield of plant-derived secondary metabolites (PDSMs), and the genetic engineering approaches for plant cell culture.

Intercept

Marine Peptides and Their Bioactive Potentials: New Horizon for Biotherapeutics,ve peptides based on the phylum from which they are derived. Moreover, we also discuss the clinical efficacy of marine peptide drugs that have reached the clinical trial phase, challenges, and future perspectives to empower peptide-based drug discovery.

可互換

Nonsteroidal Anti-Inflammatory Drug Leads from Plant Sources,cute tenosynovitis, and ankle sprains. However, due to high toxicity, the use of classical NSAIDs has been restricted. Therefore, new drugs with lower side effects and increased half-life should be developed. Multi-targeted inhibition can enhance efficacy or reduce side effects in treating inflammat